Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.

PubWeight™: 0.91‹?›

🔗 View Article (PMC 4424546)

Published in J Nanobiotechnology on April 03, 2015

Authors

Sara Maiolino1, Annapina Russo2, Valentina Pagliara3, Claudia Conte4, Francesca Ungaro5, Giulia Russo6, Fabiana Quaglia7

Author Affiliations

1: Laboratory of Drug Delivery, Department of Pharmacy, University of Napoli Federico II, Via Domenico Montesano 49, Napoli, 80131, Italy. sara.maiolino@unina.it.
2: Laboratory of Biochemistry, Department of Pharmacy, University of Napoli Federico II, Via Domenico Montesano 49, Napoli, 80131, Italy. annapina.russo@unina.it.
3: Laboratory of Biochemistry, Department of Pharmacy, University of Napoli Federico II, Via Domenico Montesano 49, Napoli, 80131, Italy. valentina.pagliara@unina.it.
4: Laboratory of Drug Delivery, Department of Pharmacy, University of Napoli Federico II, Via Domenico Montesano 49, Napoli, 80131, Italy. claudia.conte@unina.it.
5: Laboratory of Drug Delivery, Department of Pharmacy, University of Napoli Federico II, Via Domenico Montesano 49, Napoli, 80131, Italy. ungaro@unina.it.
6: Laboratory of Biochemistry, Department of Pharmacy, University of Napoli Federico II, Via Domenico Montesano 49, Napoli, 80131, Italy. giulia.russo@unina.it.
7: Laboratory of Drug Delivery, Department of Pharmacy, University of Napoli Federico II, Via Domenico Montesano 49, Napoli, 80131, Italy. quaglia@unina.it.

Articles cited by this

Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol (2010) 7.26

Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer (2004) 6.47

PLGA-based nanoparticles: an overview of biomedical applications. J Control Release (2012) 4.39

Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release (2006) 3.85

Nanoparticle delivery of cancer drugs. Annu Rev Med (2011) 3.75

Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev (2012) 3.34

Treating metastatic cancer with nanotechnology. Nat Rev Cancer (2011) 3.30

Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J (2002) 3.13

Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. ACS Nano (2008) 2.73

Nanomedicine(s) under the microscope. Mol Pharm (2011) 2.09

Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity. J Clin Invest (2009) 2.06

The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev (1995) 2.03

Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers. Nano Lett (2008) 1.96

Clinical pharmacokinetics of docetaxel. Clin Pharmacokinet (1999) 1.93

Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol (1994) 1.79

Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment. ACS Nano (2013) 1.47

Acetylation of polyethylenimine enhances gene delivery via weakened polymer/DNA interactions. Biomacromolecules (2006) 1.43

Nanomedicine therapeutic approaches to overcome cancer drug resistance. Adv Drug Deliv Rev (2013) 1.33

Formulation of Docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy. Biomaterials (2011) 1.25

Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies. Nanoscale (2013) 1.20

Nanoparticles in drug delivery: past, present and future. Adv Drug Deliv Rev (2012) 1.15

Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer. Colloids Surf B Biointerfaces (2011) 1.14

Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. Biomaterials (2013) 1.12

Advances in the field of nanooncology. BMC Med (2010) 1.11

Role of integrated cancer nanomedicine in overcoming drug resistance. Adv Drug Deliv Rev (2013) 1.03

Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials (2012) 1.01

cis-acting sequences and trans-acting factors in the localization of mRNA for mitochondrial ribosomal proteins. Biochim Biophys Acta (2008) 1.00

The architecture and biological performance of drug-loaded LbL nanoparticles. Biomaterials (2013) 0.96

Spectrophotometric determination of polyethylenimine in the presence of an oligonucleotide for the characterization of controlled release formulations. J Pharm Biomed Anal (2003) 0.96

Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes. Mol Pharm (2011) 0.95

Cationic nanoparticles have superior transvascular flux into solid tumors: insights from a mathematical model. Ann Biomed Eng (2012) 0.95

Addition of "charge-shifting" side chains to linear poly(ethyleneimine) enhances cell transfection efficiency. Biomacromolecules (2008) 0.94

Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines. Invest New Drugs (2009) 0.93

Nanoways to overcome docetaxel resistance in prostate cancer. Drug Resist Updat (2014) 0.92

Human rpL3 plays a crucial role in cell response to nucleolar stress induced by 5-FU and L-OHP. Oncotarget (2014) 0.91

Hyaluronan-decorated polymer nanoparticles targeting the CD44 receptor for the combined photo/chemo-therapy of cancer. Nanoscale (2015) 0.90

Layer-by-layer self-assembly and electrochemistry: applications in biosensing and bioelectronics. Biosens Bioelectron (2011) 0.90

Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells. Oligonucleotides (2009) 0.86

Anti-tumor immune responses of tumor-associated macrophages via toll-like receptor 4 triggered by cationic polymers. Biomaterials (2012) 0.86

Biodegradable cationic nanoparticles loaded with an anticancer drug for deep penetration of heterogeneous tumours. Biomaterials (2013) 0.86

Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer. Int J Pharm (2014) 0.84

Multi-layered nanoparticles for combination gene and drug delivery to tumors. Biomaterials (2014) 0.83

Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer. J Biomed Nanotechnol (2014) 0.83

Recent trends in cancer drug resistance reversal strategies using nanoparticles. Expert Opin Drug Deliv (2012) 0.81

Optimization of parameters for preparation of docetaxel-loaded PLGA nanoparticles by nanoprecipitation method. J Huazhong Univ Sci Technolog Med Sci (2013) 0.78

2,3,7,8-Tetrachlorodibenzo-p-dioxin promotes BHV-1 infection in mammalian cells by interfering with iron homeostasis regulation. PLoS One (2013) 0.78